Last update 17 Apr 2025

Forodesine Hydrochloride

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
(1S)-1,4-dideoxy-4-imino-(9-deazahypoxanthin-9-yl)-D-ribitol, 1,4-Dideoxy-4-aza-1-(S)-(9-deazahypoxanthin-9-yl)-D-ribitol, FDS
+ [10]
Target
Action
inhibitors
Mechanism
PNP inhibitors(Purine nucleoside phosphorylase inhibitors), Immunosuppressants
Active Organization
Drug Highest PhaseApproved
First Approval Date
Japan (31 Mar 2017),
RegulationOrphan Drug (European Union), Orphan Drug (Japan)
Login to view timeline

Structure/Sequence

Molecular FormulaC11H15ClN4O4
InChIKeyWEIAMZKHBCLFOG-QPAIBFMUSA-N
CAS Registry284490-13-7

External Link

R&D Status

Approved
10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Peripheral T-Cell Lymphoma
Japan
31 Mar 2017
Developing
10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Pre B-cell acute lymphoblastic leukemiaPhase 2
Austria
01 Mar 2009
Pre B-cell acute lymphoblastic leukemiaPhase 2
Czechia
01 Mar 2009
Pre B-cell acute lymphoblastic leukemiaPhase 2
France
01 Mar 2009
Pre B-cell acute lymphoblastic leukemiaPhase 2
Germany
01 Mar 2009
Pre B-cell acute lymphoblastic leukemiaPhase 2
Italy
01 Mar 2009
Pre B-cell acute lymphoblastic leukemiaPhase 2
United Kingdom
01 Mar 2009
Refractory T Acute Lymphoblastic LeukemiaPhase 2
Austria
01 Mar 2009
Refractory T Acute Lymphoblastic LeukemiaPhase 2
Czechia
01 Mar 2009
Refractory T Acute Lymphoblastic LeukemiaPhase 2
France
01 Mar 2009
Refractory T Acute Lymphoblastic LeukemiaPhase 2
Germany
01 Mar 2009
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 2
48
tgnindvyct(vhpiexuhwc) = nmadmvzyru hkepyrkrcf (ssaxwnqwmv, 14 - 38)
Positive
01 Jan 2019
Phase 1/2
44
mfzhwdrxtf(hsmakbwfpe) = oqnwvftjtg winudmiykk (oifypqblhi, 12.0 - 35.3)
Positive
20 May 2016
Phase 2
144
ifnlgjwmcq(idphxuisfs) = ejctjvtjsz yylugropjm (rybcnzqlkp )
-
01 Sep 2014
Phase 2
8
Oral forodesine 200 mg/d
atbvyhmcqu(knmjdmujup) = vofzbjydya uhkfxxybdo (doyjpbgfsz )
-
12 Aug 2010
Not Applicable
64
dvcwjaqcuv(uvrxudpisu) = bsmzqrsumf zdmyqikyqh (cwcpgykqaw )
-
20 May 2009
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free